These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 21288700)
1. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles. Kuo YC; Yu HW Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700 [TBL] [Abstract][Full Text] [Related]
2. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug. Kuo YC; Yu HW Colloids Surf B Biointerfaces; 2011 Nov; 88(1):158-64. PubMed ID: 21764569 [TBL] [Abstract][Full Text] [Related]
3. Loading efficiency and surface conductance of heparin-modified poly(lactide-co-glycolide) nanoparticles. Kuo YC; Shih KH Colloids Surf B Biointerfaces; 2009 Jul; 71(2):282-7. PubMed ID: 19329287 [TBL] [Abstract][Full Text] [Related]
4. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. Chung TW; Wang SS; Tsai WJ Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984 [TBL] [Abstract][Full Text] [Related]
5. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid). Kuo YC; Yu HW Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932 [TBL] [Abstract][Full Text] [Related]
6. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Zeng P; Xu Y; Zeng C; Ren H; Peng M Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597 [TBL] [Abstract][Full Text] [Related]
7. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles. Ozturk K; Caban S; Kozlu S; Kadayifci E; Yerlikaya F; Capan Y Pharmazie; 2010 Sep; 65(9):665-9. PubMed ID: 21038843 [TBL] [Abstract][Full Text] [Related]
8. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
9. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures. Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395 [TBL] [Abstract][Full Text] [Related]
12. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells. Han R; Zhu J; Yang X; Xu H J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162 [TBL] [Abstract][Full Text] [Related]
13. Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles. Ghotbi Z; Haddadi A; Hamdy S; Hung RW; Samuel J; Lavasanifar A J Drug Target; 2011 May; 19(4):281-92. PubMed ID: 20590403 [TBL] [Abstract][Full Text] [Related]
14. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency. Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795 [TBL] [Abstract][Full Text] [Related]
15. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles. Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878 [TBL] [Abstract][Full Text] [Related]
16. Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid-poly(lactide-co-glycolide) nanoparticles: from fabrication to preclinical validation. Mondalek FG; Ashley RA; Roth CC; Kibar Y; Shakir N; Ihnat MA; Fung KM; Grady BP; Kropp BP; Lin HK J Biomed Mater Res A; 2010 Sep; 94(3):712-9. PubMed ID: 20213816 [TBL] [Abstract][Full Text] [Related]
17. Composites of poly(lactide-co-glycolide) and the surface modified carbonated hydroxyapatite nanoparticles. Hong Z; Zhang P; Liu A; Chen L; Chen X; Jing X J Biomed Mater Res A; 2007 Jun; 81(3):515-22. PubMed ID: 17133447 [TBL] [Abstract][Full Text] [Related]
18. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055 [TBL] [Abstract][Full Text] [Related]